Search results
Bristol Myers (BMY) Gains 24.2% YTD: What's in Store for 2023?
Zacks via Yahoo Finance· 2 years agoBiotech giant Bristol Myers (BMY) outperforms the industry and the S&P 500 Index as Eliquis and...
Which Is the Better Passive Income Stock, Eli Lilly or Bristol Myers Squibb?
Motley Fool· 1 year agoMost pharma investors are familiar with power players like Eli Lilly (NYSE: LLY) and Bristol Myers...
With Shares Trading Near All-Time Highs, Is Now the Time to Take Profits in Novo Nordisk?
Motley Fool via Yahoo Finance· 3 months agoIf you aren't familiar with the Danish pharmaceutical company Novo Nordisk (NYSE: NVO), I bet you've...
What Impact Will Medicare Price Negotiations Have on Big Pharma Stocks?
Motley Fool· 9 months agoWhen Joe Biden ran for president in 2020, he promised to allow Medicare to negotiate directly with...
The Zacks Analyst Blog Highlights Merck, Bristol-Myers Squibb and Deere
Zacks via Yahoo Finance· 1 year agoFor Immediate Release Chicago, IL – December 12, 2022 – Zacks.com announces the list of stocks...
The Unexpected Bad News For Novo's Ozempic In Biden's Drug Negotiations List
Investor's Business Daily· 9 months agoThere's a piece of bad news for Novo Nordisk's massively popular diabetes drug Ozempic in Medicare's...
Bristol Myers, Pfizer, AbbVie drugs likely to face U.S. price negotiation
Reuters via Yahoo Finance· 1 year agoThe blood thinner Eliquis from Bristol Myers Squibb, Pfizer's breast cancer drug Ibrance and...
2 Pharma Stocks With Blockbuster Drugs on the Horizon
Motley Fool· 2 years agoAbbVie's Humira, used to treat inflammatory conditions such as rheumatoid arthritis, psoriatic...
The Zacks Analyst Blog Highlights Biogen, Bristol Myers Squibb, Incyte and Vertex Pharmaceuticals
Zacks via Yahoo Finance· 1 month agoFor Immediate Release Chicago, IL – April 26, 2024 – Zacks.com announces the list of stocks featured...
Merck Reverses Higher As Keytruda, Gardasil Outplay Covid Decline; Bristol Shares Dip
Investor's Business Daily· 1 year agoMerck topped Wall Street's first-quarter forecasts Thursday while Bristol Myers Squibb delivered a...